Bloomberg Audio Studios, Podcasts, Radio News, The Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data, take a look with some of the stocks on the move today.
We can do that with Natalians Kenny Javic Bloomberg News.
She covers the markets Force Natalia.
What are you looking at, guys? Let's start with Gemini space Station the tickets Gemi. The stock is up by five point five point five percent today. The company received Designated Contract Market License from the CFTC, which would allow Gemini to offer production markets in the US, So basically, US customers will be able to trade event contracts on website or mobile app. Analysts are very optimistic about this development. They are saying that that could allow the company to
increase database of clients and transaction volume, et cetera. But keep in mind the stock is still down by almost sixty percent from its IPO. What about the stock of the past twenty four hours Oracle Oracle Yes, so the ticker is our cl The stock is down by fifteen percent today. Disappointing cloud revenue forecast for third quarter sales also came below expectation. So basically, fifteen billion dollar increase in fiscal year capex target comes on the back of
ten billion dollars of cash outflow. The main takeaway here is that analysts are becoming a little bit our investors right concerned that this huge backlock of orders can eventually turn into profitable revenue stream. So now we see also some competition from other companies including Alphabet's Google, and there are many concerns around this space. So that is why the stock is also down today. But our friends Eli
Lilly l Y is a ticker. Yeah, so shares of Li Lilly are basically flat, but earlier today they jump by almost four percent. This is the very big development. So the company got good results from an experimental next generation a B city shot with a very complicated name. It's Ritra Rita treat Tide. Yeah, I don't even go I love it. So basically it shows that patients with the highest dose of this drug lost more than twenty three percent of their by weight in sixty eight weeks.
Analysts are very encouraged about that. They're saying that that could be best best in class weight loss a drug. And twenty twenty six, of course, will bring more news on that, but as of now, it is a very positive development for.
This up the Stock Mover's report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to bloom Burg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.